[No improvement of therapeutic results by modulation of 5-fluorouracil with leucovorin and/or levamisole in adjuvant radiochemotherapy in rectal carcinoma].
Fietkau
R
R
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage; D007978:Levamisole / Q000008:administration & dosage; D011379:Prognosis; D012004:Rectal Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*
D007978:Levamisole; D002955:Leucovorin; D005472:Fluorouracil
Keine besseren Therapieergebnisse durch Modulation von 5-Fluorouracil mit Leukovorin und/oder Levamisol in der adjuvanten Radiochemotherapie des Rektumkarzinoms.